Cypress Capital Management (Delaware)’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $239K | Hold |
|
|||||
|
2018
Q3 | $318K | Sell |
|
|||||
|
2018
Q2 | $286K | Hold |
|
|||||
|
2018
Q1 | $278K | Sell |
|
|||||
|
2017
Q4 | $301K | Hold |
|
|||||
|
2017
Q3 | $294K | Sell |
|
|||||
|
2017
Q2 | $313K | Sell |
|
|||||
|
2017
Q1 | $365K | Sell |
|
|||||
|
2016
Q4 | $355K | Sell |
|
|||||
|
2016
Q3 | $2.44M | Sell |
|
|||||
|
2016
Q2 | $2.41M | Sell |
|
|||||
|
2016
Q1 | $2.42M | Sell |
|
|||||
|
2015
Q4 | $3.12M | Buy |
|
|||||
|
2015
Q3 | $1.66M | Buy |
|
|||||
|
2015
Q2 | $838K | Buy |
|
|||||
|
2015
Q1 | $731K | Buy |
|
|||||
|
2014
Q4 | $621K | Buy |
|
|||||
|
2014
Q3 | $460K | Buy |
|
|||||
|
2014
Q2 | $307K | Buy |
|